These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30009386)

  • 21. Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases.
    Ingen-Housz-Oro S; Bernier C; Gener G; Fichel F; Barbaud A; Lebrun-Vignes B; Assier H
    Br J Dermatol; 2019 Mar; 180(3):666-667. PubMed ID: 30222854
    [No Abstract]   [Full Text] [Related]  

  • 22. Reactivation of Skin Lesions After Patch Testing to Investigate Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
    Córdoba S; Navarro-Vidal B; Martínez-Morán C; Borbujo J
    Actas Dermosifiliogr; 2016 Nov; 107(9):781-783. PubMed ID: 27340118
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.
    Turney R; Skittrall JP; Donovan J; Agranoff D
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS).
    Chou HY; Chen CB; Cheng CY; Chen YA; Ng CY; Kuo KL; Chen WL; Chen CH
    J Clin Pharm Ther; 2015 Dec; 40(6):689-92. PubMed ID: 26365588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first case of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by apalutamide, a novel oral androgen receptor antagonist.
    Ducharme O; Sanchez-Pena P; Pham-Ledard A; Beylot-Barry M; Milpied B
    Contact Dermatitis; 2022 Apr; 86(4):313-315. PubMed ID: 34890059
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of DRESS (drug reaction with eosinophilia and systemic symptoms) under treatment with eslicarbazepine.
    Willikens S; Wolking S
    Seizure; 2019 Nov; 72():11-12. PubMed ID: 31541846
    [No Abstract]   [Full Text] [Related]  

  • 27. [DRESS syndrome].
    Adamcová M; Šturdík I; Koller T; Payer J
    Vnitr Lek; 2016 Apr; 62(4):334-7. PubMed ID: 27250614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
    Huang YC; Shih PY; Chin SY; Chiang YY
    J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rhinorrhea as side-effect of spironolactone].
    Ayerbe García-Monzón L; Herrero Hernández S; González López E; Alcaraz Borrajo M
    Aten Primaria; 2004 Feb; 33(3):164. PubMed ID: 14987504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Allopurinol-induced DRESS complicated by hemophagocytic lymphohistiocytosis].
    Korbi M; Youssef M; Ben Brahim H; Chaabane A; Mohamed M; Akkari H; Belhadjali H; Zili J
    Ann Dermatol Venereol; 2015 Dec; 142(12):767-70. PubMed ID: 25982828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug reaction with eosinophilia and systemic symptoms syndrome.
    Spriet S; Banks TA
    Allergy Asthma Proc; 2015; 36(6):501-5. PubMed ID: 26534757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol-induced acute kidney injury and DRESS syndrome without eosinophilia: A case report.
    Liu Q; Hou W; Shen Y; Zhao S
    Clin Nephrol; 2021 Sep; 96(3):188-190. PubMed ID: 34338190
    [No Abstract]   [Full Text] [Related]  

  • 34. Rivaroxaban-Induced Drug Reaction With Eosinophilia and Systemic Symptoms.
    Radu C; Barnig C; de Blay F
    J Investig Allergol Clin Immunol; 2016; 26(2):124-6. PubMed ID: 27164633
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril-induced DRESS: first reported case confirmed by patch test.
    Chaabane A; Fadhl NB; Chadly Z; Fredj NB; Boughattas NA; Aouam K
    Dermatitis; 2013; 24(5):255-7. PubMed ID: 24030372
    [No Abstract]   [Full Text] [Related]  

  • 37. [Venous thrombosis, unrecognized complication of DRESS].
    Medhioub Kaaniche F; Allela R; Ben Algia N; Cherif S; Attar M; Frikha I; Mnif M
    Ann Dermatol Venereol; 2017 Feb; 144(2):121-124. PubMed ID: 27522939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil.
    Fargeas M; Calugareanu A; Ben-Said B
    Contact Dermatitis; 2022 Aug; 87(2):203-204. PubMed ID: 35419842
    [No Abstract]   [Full Text] [Related]  

  • 39. DRESS syndrome: a detailed insight.
    Behera SK; Das S; Xavier AS; Selvarajan S
    Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium-paraaminobenzoic acid (Potaba®)-associated DRESS syndrome.
    Viehweg A; Stein A; Bauer A; Spornraft-Ragaller P
    Dermatitis; 2013; 24(5):257-8. PubMed ID: 24045650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.